Amylyx Pharmaceuticals, Inc. ( AMLX) - Key Metrics
AMLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.35 | -$0.30 | -$0.30 |
| 2025Q3 | ? | -$0.37 | -$0.33 | -$0.33 |
| 2025Q2 | ? | -$0.46 | -$0.28 | -$0.28 |
| 2025Q1 | ? | -$0.42 | -$0.46 | -$0.46 |
AMLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.65 |
| 2025Q3 | ? | -9.22 |
| 2025Q2 | ? | -3.45 |
| 2025Q1 | ? | -2.11 |
AMLX
Price: $13.91
52 week price:
Earnings Per Share: -1.48 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 390250
Market Capitalization: 1.1 billion